Pharmaceutical startup Balanced Pharma has named Dr. Howard Glazer to its scientific advisory board.
Dr. Howard Glazer.
Glazer joins the board as the company moves toward the commercialization of BPI-001 and BPI-002, which aim to offer less painful, faster-acting dental anesthesia injections. Balanced Pharma's patented container technology delivers acid-free formulations of lidocaine/epinephrine and articaine/epinephrine in a standard dental cartridge.
Glazer is a fellow and past president of the Academy of General Dentistry and a former assistant clinical professor in dentistry at the Albert Einstein College of Medicine in New York.
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
